Is GALAPAGOS NV (GLPG) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.5% / 30% | 143.7% / 30% | 4.1% / 30% | 32.57% / 5% | ✗ NOT HALAL |
| DJIM | 0.5% / 33% | 143.7% / 33% | 4.1% / 33% | 32.57% / 5% | ✗ NOT HALAL |
| MSCI | 0.3% / 33% | 75.4% / 33% | 2.1% / 33% | 32.57% / 5% | ✗ NOT HALAL |
| S&P | 0.5% / 33% | 143.7% / 33% | 4.1% / 33% | 32.57% / 5% | ✗ NOT HALAL |
| FTSE | 0.3% / 33% | 75.4% / 33% | 2.1% / 50% | 32.57% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 57.5% | |
| Operating Margin | 86.0% | |
| Net Margin | 28.8% | |
| Return on Equity (ROE) | 10.4% | |
| Return on Assets (ROA) | 8.6% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$320M |
| Free Cash Flow | -$402M |
| Total Debt | $12M |
| Debt-to-Equity | 0.2 |
| Current Ratio | 20.1 |
| Total Assets | $4.1B |
Price & Trading
| Last Close | $29.97 |
| 50-Day MA | $33.26 |
| 200-Day MA | $32.20 |
| Avg Volume | 112K |
| Beta | 0.1 |
|
52-Week Range
$22.59
| |
About GALAPAGOS NV (GLPG)
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is GALAPAGOS NV (GLPG) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), GALAPAGOS NV is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is GALAPAGOS NV's debt ratio?
GALAPAGOS NV's debt ratio is 0.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.3%.
What are GALAPAGOS NV's key financial metrics?
GALAPAGOS NV has a market capitalization of $1.9B, trailing P/E ratio of 5.2, and revenue of $276M. The company maintains a gross margin of 57.5% and a net margin of 28.8%. Return on equity stands at 10.4%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.